Vedolizumab - Open Access .click

Results 71 to 80 of about 15,943 (150)

Safety and efficacy of granulocyte/monocyte apheresis in steroid-dependent active ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologics (ART trial): 12-week interim results

, 2016
International audienceBACKGROUND AND AIMS: Patients with active, steroid-dependent ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologic therapies have limited treatment options.
Akbar, Ayesha +11 more
core +3 more sources

Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease [PDF]

, 2017
Patients with inflammatory bowel disease (IBD) are at increased risk for developing symptomatic Clostridium difficile infection (CDI) with worse clinical outcomes, including mortality, as compared with the general population.
Vitikainen, Krista
core

Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando et al [PDF]

, 2017
Elewaut, Dirk, Van den Bosch, Filip, Varkas, Gaëlle +2 more
core +2 more sources

Clinical utility of anti-TNFα trough levels and anti-drug antibodies in the management of inflammatory bowel disease [PDF]

, 2015
1. Introduction The inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal (GI) tract that are associated with significant morbidity and disability.
BIANCHETTI, D.
core

Reporting quality of randomized clinical trials for anti-TNF agents for Chron's disease published from 2005 to date using the CONSORT statemen [PDF]

, 2015
Γκουγκουλής, Δημήτριος Α
core +1 more source

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease [PDF]